Burlington, MA-based ConforMIS, which custom-builds implants for less-invasive knee surgery and is in the midst of an expansion push, today announced the commercial launch of an implant for partial knee replacement. The device was approved by the FDA in 2005 but, as I mentioned when I profiled ConforMIS last fall, the company has taken the unusual tack of performing additional clinical trials on each of its approved devices before marketing them.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
